Parenchymal Lung Diseases and Sarcoidosis Flashcards

1
Q

Pulmonary Interstitium

Components

A
  • BM of endothelial & epithelial cells
  • Collagen fibers
  • Elastic tissue
  • Proteoglycans
  • Fibroblasts
  • Mast cells
  • Few lymphocytes and monocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diffuse Parenchymal Lung Diseases (DPLD)

Overview

A

Diffuse and predominantly chronic changes of the pulmonary CT.

  • Affects most peripheral and delicate interstitium in alveolar walls
  • Diseases share clinical signs, sx, radiographic ∆, and pathophysiologic ∆
    • ± Intra-alveolar component
    • Freq. overlap in histologic features
  • Many have unknown etiologies
  • Accounts for 15% of noninfectious pulmonary diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DPLD

Known Etiologies

A
  • Environmental
    • Asbestos
    • Silica
    • Fumes
    • Gases
  • Ionizing radiation
  • Sequela of ARDS
  • Drugs
    • Busulfan
    • Bleomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DPLD

Pathogenesis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DPLD

Clinical Features

A

See clinical and pulmonary functional changes of restrictive disease:

  • Dyspnea & tachypnea ⇒ eventual cyanosis without wheezing
  • ↓ Oxygen diffusing capacity
  • ↓ Lung volumes
  • ↓ Compliance
  • Pulmonary HTN
  • Cor pulmonale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DPLD

Radiographic Features

A

Diffuse infiltration by small nodules or shadows

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DPLD

Morphology

A

Similar histologic appearance in late stages:

Honeycomb lung or end-stage lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diffuse Parenchymal Lung Diseases

Types

A
  1. Idiopathic Pulmonary Fibrosis
  2. Non-specific Interstitial PNA
  3. Desquamative Interstitial PNA
  4. Acute Interstitial PNA
  5. Cryptogenic Organizing PNA
    • aka Bronchiolitis Obliterans with Organizing PNA (BOOP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Idiopathic Pulmonary Fibrosis

Epidemiology

A
  • Age > 60 years
  • 7-16 cases/100k
  • ♂ > ♀
  • 75% former or current smokers
  • Rare familial cases
  • Poor prognosis ⇒ 5 year survival rate 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Idiopathic Pulmonary Fibrosis

Possible Causes

A
  • Alveolitis ⇒ Fibrosis
    • Repeated cycles of alveolitis provoked by unknown agent
  • Direct fibrosis
  • Aberrant wound healing with fibroblastic proliferation
  • Peripheral location ⇒ effect of gravity or aspiration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IPF

Histology

A

Termed “Usual Interstitial Pneumonia” (UIP)

Pathological definition

Patchy fibrosis most prominent in subpleural region

Temporal heterogeneity ⇒ alternating zones of inflammation, active fibrosis, scarring, honeycomb and normal lung

Usually affects lower lobes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

IPF

Radiology

A

Generally lower lobe and peripheral interstitial changes.

Central lung and upper lobe sparing typical.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IPF

Treatment

A
  • No proven therapy
  • Poor response to corticosteroids & combo therapy
  • Clinical trials ongoing
    • Anti-fibrotic drugs ⇒ some slowing of progression
  • Supportive care
    • Pulmonary rehab
    • Vaccines
    • Nutrition
    • Cough control
  • Only definitive therapy is lung transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non-specific Interstitial Pneumonia (NSIP)

Epidemiology

A
  • Associations ⇒ HIV, CT diseases, drugs
  • Onset 5th and 6th decades
    • Earlier than IPF
  • Insidious onset
  • No male/female predominance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NSIP

Histology

A

Cellular and fibrosing patterns

Temporal uniformity ⇒ suggests that NSIP is not due to recurrent sequential bouts of alveolitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NSIP

Radiology

A

CXR not necessarily able to differentiate NSIP from IPF.

CT can show a ground glass appearance (alveolar pattern)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

NSIP

Treatment

A
  • Steroids and other immune modulators may be helpful
  • Treat underlying rheumatologic disease if present
  • Outcomes extremely variable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diffuse Interstitial Pneumonia (DIP)

Epidemiology

A

“Desquamative Interstitial Pneumonia”

  • Exclusively in smokers
    • Usually heavy 30+ pack years
  • Onset in 4th and 5th decade
  • More common in men
  • 8% of total IPF cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DIP

Histology

A
  • Airspaces ⇒ many Mφ with brown pigment (yellow star)
  • Alveolar septae thickened with lymphocytic infiltrate
  • Prominent pneumocytes (arrow)
  • Mild interstitial fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

DIP

Radiology

A

More lower lobe involvement.

Ground glass appearance on CT

Milder changes compared to others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

DIP

Treatment

A
  • Quit smoking
  • Steroids if needed
  • Generally a good prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cryptogenic Organizing Pneumonia (COP)

Overview

A

“Bronchiolitis Obliterans Organizing Pneumonia” (BOOP)

  • Etiology unknown
    • Often linked to viral, drug, or cardiovascular disease
    • Idiopathic
  • Pt presents with subacute cough and SOB
  • Onset 5th decade most commonly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

COP

Histology

A
  • Polypoid plugs of loose organizing CT within airspaces
  • Do not see interstitial fibrosis or honeycomb lung
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

COP

Radiology

A

Subpleural or peribronchial patchy areas of airspace consolidation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
COP Treatment
Responds well to several months of **steroids**.
26
Acute Interstitial Pneumonia (AIP) Pathophysiology
"Hamman-Rich Syndrome" * **Pathologic features of ARDS appears acutely in pt without known triggers** * **Fulminant presentation** * Rapid progressive clinical course * Average age 50-55 y/o * Not smoking related
27
AIP Histology / Pathology
Termed **diffuse alveolar damage (DAD)** * ↑ Pulmonary vascular permeability * Interstitial inflammation * Epithelial cell death * **See hyaline membranes lining alveolar spaces**
28
AIP Radiology
Diffuse, bilateral alveolar infiltrates.
29
Interstitial Lung Disease Clinical Approach
* History * Age * Fhx * Drugs, CT diseases, dust exposure, Beryllium, World Trade Center, etc. * Physical exam * CXR
30
DPLD Summary Table
31
Sarcoidosis Definition
_Need all 3 of the following:_ * Compatible clinical symptoms * Evidence of non-caseating granulomas * Rule out other causes of granuloma
32
Sarcoidosis Epidemiology
* Affects all races and ethnic groups * **♀ \> ♂** * Peak incidence age **20-39 y/o** * Most affected populations: * Northern Europeans * Japan * African Americans
33
ACCESS Study
No single predominant cause of sarcoidosis found.
34
Sarcoidosis Environmental Associations
* Beryllium * Inhalation of inorganic particles * World Trade Center * Wood burning stoves * Moldy environments * Occupational exposures * US Navy, firefighters, metal workers, buliding supplies, agricultural employment * Insecticides
35
Sarcoidosis Infectious Associations
* Microbial bioaerosols * Nontuberculous mycobacterial DNA * Ab to Mycobacterium tubeculosis Ag and proteins * Propionibacterium RNA
36
Sarcoidosis Pathophysiology
* Inciting Ag unknown * **Mφ** stimulation w/ **CD4+ T-cell** activation * Predominant CD4+ response w/ **variable Th1/Th2** paths ⇒ stimulates **fibroblast proliferation** ⇒ collagen production ⇒ **progressive fibrosis** * **Pulmonary Sarcoid granulomas** **form** * Epithelioid giant cells * Granulomas ⇒ persist, resolve, fibrosis
37
Sarcoidosis Histology
**Non-caseating granulomas which eventual hyalinize.** * **Giant cells** * **Schaumann bodies** ⇒ concentric laminations of calcium or proteins * **Asteroid bodies** ⇒ stellate inclusions
38
Sarcoidosis Clinical Features
* **May be asymptomatic** ⇒ incidental finding on CXR * **Systemic sx** ⇒ fever, fatigue, night sweats * Other specific sx related to organ involvment * General course: * **⅔ resolve spontaneously** * **⅓ develop fibrosis w/ varying organ dysfunction**
39
Sarcoidosis Organ Involvement
Any organ or tissue may be involved. * Common sites * **Lung** * **Skin** * **Eye** * Less common * Brain and nerves * Heart * Liver and spleen * Bone and joints * Kidney
40
Pulmonary Sarcoidosis Radiographic Stages
Stages do not correlate w/ sx, chronicity, or pulmonary function.
41
Pulmonary Sarcoidosis Symptoms
Asymptomatic Dyspnea Cough
42
Pulmonary Sarcoidosis PFTs
* 50% ⇒ restrictive pattern * 40% ⇒ combined restrictive and obstructive pattern * **DLCO ⇒ most sensitive indicator of disease** * Most have a bronchodilator response
43
Cutaneous Sarcoidosis Manifestations
* Erythema nodosum * Macules, plaques, and papules * Lupus pernio * Löfgren's syndrome
44
Erythema Nodosum
* **SubQ erythematous nodules** * **Lymphocytic panniculitis of SubQ fat** * Usually pretibial * Painful * **Usually self-limiting and benign** * Seen in younger women
45
Sarcoid Macules, Plaques, and Papules
* **Often contain granulomas** * Locations: * Neck, upper back and trunk, extremities * Areas of previous scars * Tattoos * **Associated with chronic, poorly responsive disease**
46
Lupus Pernio
* **Violaceous nodules on nose, cheeks, and lips** * Associated w/ chronic disease & extrapulmonary involvement * Contains granulomas
47
Löfgren's Syndrome
* _Triad of findings_ 1. **Polyarticular large joint arthritis** 2. **Erythema nodosum** 3. **Bilateral hilar adenopathy on CX**R * Acute presentation * **Often resolves spontaneously or w/ short course of steroids**
48
Hepatosplenic Sarcoidosis
* Occurs in 10% of sarcoid pts * Associated with systemic sx * **Fever, night weats, anorexia, weight loss** * Labs: * ↑ Bilirubin, Alkaline phosphatase * Normal transaminases * **Severe hepatic manifestations** ⇒ 1% * Portal HTN w/ varices * Hepatopulmonary syndrome * Cirrhosis and liver failure
49
Cardiac Sarcoid
* **Granulomatous inflammation and scarring in LV free wall & septum** * Septal affects conducting system * Presentation: * **Restrictive cardiomyopathy** * Dyspnea on exertion, orthopnea, PND * **Conduction abnormalities** * Tachyarrhythmias, bradyarrhythmias, LOC * Diagnosis: * Biopsies often unhelpful * Biopsy site RV, involvement is LV * **Cardiac MRI or PET scan** * EP study * Found in ~ 25% of cases at autopsy * Clinically apparent in 5%
50
Renal Sarcoidosis
* Sarcoid Mφ have high levels of 25-OH-Vit D hydroxylase * Converts 25-OH Vit D → 1,25-OH Vit D * **↑ calcium absorption ⇒ hypercalcemia and hypercalciuria** * **May cause renal calculi and obstruction** * **Renal failure d/t granulomatous nephritis rare** * Renal disease management * Monitor calcium levels yearly w/ active sarcoidosis * Check 24 hr urinary calcium excretion * **↑ serum or urinary calcium excretion may warrant systemic sarcoid treatment**
51
Neurologic Sarcoidosis
* 25% @ autopsy, **10% clinical involvement** * Manifestations: * **Cranial-nerve palsies** * **Headache** * **Ataxia** * **Cognitive dysfunction** * **Weakness** * **Seizures** * Diagnosis: * MRI ⇒ periventricular white matter ∆ * Lumbar puncture ⇒ nonspecific * Lymphocytes, Oligoclonal bands, ↑ ACE levels
52
Ocular Sarcoidosis
* Seen in 25% of cases * **75% have anterior uveitis (iritis)** * Acute or chronic * Sx: **blurred vision, tearing, photophobia** * May lead to **glucoma** and **vision loss** * **30% have posterior uveitis** * Ass. w/ CNS involvement * **Conjunctiva may show yellow nodules or cysts** * **Lacrimal glands involvement** ⇒ dry eyes * All sarcoid pts should have yearly eye exams
53
Sarcoidosis Clinical Evaluation
* History w/ attention to environmental/occupational exposures, fhx * CXR * PFTs * EKG * Slit lamp eye exam * Biopsy of affected organ
54
Sarcoidosis Differentials
* Infectious * Typical and atypical TB * Fungal * Brucellosis * Rhematologic * Juvenile RA * Polyangiitis w/ granulomatosis * Rheumatoid nodules * Lymphoma * Hypersensitivity pneumonitis * Berylliosis * Inflammatory bowel disease * Granulomatous hepatitis * FB aspiration or IV injection * Common variable immunodeficiency * Lung CA
55
Sarcoidosis Treatment Principals
* Dx is not an indication for treatment * Most manifestations are asymptomatic and not disabling * Many manifestations are self-limiting * Consider instituting therapy when organ function is threatened * Brain, heart, hypercalcemia
56
Sarcoidosis Therapy
* Initial therapy * Prednisone PO * Re-evaluate response at 1-3 months * Decrease to lowest effective dose for 9-12 months * Failure of steroids * Consider immunosuppressive or cytotoxic agents * Methotrexate * Azathioprine * Hydroxychloroquine * Infliximab or other anti-TNF agent
57
Hypersensitivity Pneumonitis Characteristics
_A granulomatous disease:_ **Spectrum of predominantly interstitial lung disorders caused by intense and prolonged exposure to inhaled organic dusts:** ⇒ Thermophilic bacteria ⇒ True fungi ⇒ Animal protein ⇒ Bacterial products
58
Farmer's Lung
Hypersensitivity pneumonitis caused by: ## Footnote **Harvested, humid hay which grows thermophilic actinomyces**
59
Pigeon-Breeder's Lung
Hypersensitivity pneumonitis caused by: ## Footnote **Proteins from bird excreta and feathers**
60
Humidifier or Air Conditioner Lung
Hypersensitivity pneumonitis caused by: ## Footnote **Thermophilic bacteria in heated water reservoirs**
61
Hypersensitivity Pneumonitis Types Summary
62
Hypersensitivity Pneumonitis Clinical Features
* _Acute form_ * Sx appear **4-6 hours** after exposure * Recurrent attacks of **fever, SOB, cough, and leukocytosis** * Diffuse and nodular infiltrates on CXR * PFT w/ restrictive pattern * Early in disease course, progression prevented by removal of agent * Continued exposure ⇒ _chronic form_ * **Progressive respiratory failure** * **SOB** * **Cyanosis** * **↓ TLC and compliance**
63
Hypersensitivity Pneumonitis Histology
* Left ⇒ **Interstitial pneumonitis** * Lymphocytes, Mφ, and plasma cells expand width of alveolar septa * Middle ⇒ **Interstitial fibrosis w/ inflammatory cells in thickened speta** * Right ⇒ **Granuloma formation**
64
Pulmonary Eosinophilia
_Several diseases w/ eosinophlic infiltration:_ * **Acute eosinophilic PNA** w/ respiratory failure * **Simple pulmonary eosinophilia** (Loffler syndrome) * **Tropical eosinophilia** 2/2 microfilarial infection * **Secondary eosinophlia** * D/t various infections, hypersensitivity pneumonitis, drug allergies, asthma * **Chronic eosinophilic PNA**
65
Pneumoconioses Characteristics
**Non-neoplastic lung reaction to inhalation of mineral dusts or other particles or vapors.** * Agents: * **Coal dust** * **Silica** * **Asbestos** * **Beryllium** * Development depends on: * Size, shape, and bouyancy of particles * Concentration in air * Duration of exposure * Particle solubility and physiochemical reactivity * Additional effects of other irritants
66
Pneumoconioses Types
* Coal Workers Pneumoconiosis (CWP) * Anthracosis * Simple CWP * Complicated CWP * Silicosis * Abestosis * Berylliosis
67
Anthracosis
* Asymptomatic * Carbon pigment in Mφ, CT, lymphoid tissue
68
Simple CWP
* Accumulation of Mφ * Little or no pulmonary dysfunction * Coal macules & coal nodules * Upper lobes and upper zones of lower lobes
69
Complicated CWP
"**Progressive Massive Fibrosis (PMF)** or **Black Lung**" * Extensive fibrosis * Pulmonary function compromised * Takes many years to develop * Multiple large blackened scars: 2-10 cm * Pigment and dense collagen
70
Silicosis Characteristics
* **Most prevalent occupational disease in the world** * Presents after decades of exposure to **sandblasting, mining, stone cutting** * Silica occurs in _amorphous and crystalline forms_ * Crystallin form more fibrogenic
71
Silicosis Histology
* Tiny, barely palpable nodules initially * Pale to black depending on ± coal dust * Coalesce ⇒ **hard collagenous scars containing** **silica particles** * **May undergo central softening** ⇒ superimposed TB or ischemia * **Eggshell calcification** * Intervening parenchyma compressed or over-expanded ⇒ **honeycomb pattern** * Can end as **Progressive Massive Fibrosis**
72
Abestos
Two distinct geometric forms: * **Serpentine** ⇒ curly and flexible fibers * Chrysolite ⇒ used in industry * **Amphibole** ⇒ straight, stiff, brittle fibers * Crocidolite, amosite, tremolite, anthophyllite, actinolyte * Less prevalent but more pathogenic * Esp. mesotheliomas
73
Asbestosis Clinical Manifestations
Can show many different clinical pictures: * Pleural plaques * Pleural effusions * **Parenchymal intersitial fibrosis (aka asbestosis)** * **Mesothelioma** * Bronchogenic carcinoma * Laryngeal and other extrapulmonary neoplasms
74
Asbestos Gross Effects
* **Affects lower lobes and subpleural areas first** * Middle & upper lobes affected as fibrosis progresses * Visceral pleura ⇒ **fibrous thickening** * Parietal pleura ⇒ **pleural plaques** * Made of dense collagen and calcium
75
Asbestosis Pathogenesis
"Parenchymal Interstitial Fibrosis" 1. Fibrosis of respiratory bronchioles & alveolar ducts 2. Fibrosis of alveolar sacs and alveoli 3. Diffuse pulmonary interstitial fibrosis 4. Honeycomb lung
76
Abestosis Histology
**Asbestos bodies** ⇒ fusiform beaded rods w/ translucent center **Ferruginous body** ⇒ asbestos body coated with iron-containing proteinaceous material
77
Coal vs Silica vs Asbestos
78
Berylliosis
* **Aerospace and nuclear industries** * Acute exposure ⇒ almost non-existent, regulated * _Chronic exposure_ ⇒ **non-caseating pulmonary granulomas with hilar lymphadenopathy** * Less common in spleen and liver * Caused by induction of _cell-mediated immunity_ * **Heavy exposure linked to lung cancer**